Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076622 · ClinicalTrials.gov registry record
Medication Treatment for Depression in Nursing Home Residents
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 94
- Enrollment target
NCT00076622: Completed study, sponsored by University of Pennsylvania.
NCT00076622 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00076622 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
This study will examine therapeutic and adverse effects of continuing versus discontinuing antidepressant medication in nursing home residents who have had no more than a single episode of depression and who no longer have depressive symptoms.
Primary Outcome
The GDS scale measures presence and severity of depressive symptoms in older adults. Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).
Interventions
- DRUG Antidepressant medication
- DRUG No antidepressant medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2003-11 |
| Est. Completion | 2009-07 |
What the finished NCT00076622 record still lists
NCT00076622 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Antidepressant medication is the first listed.
NCT00076622 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00076622 about?
NCT00076622 is a clinical study titled "Medication Treatment for Depression in Nursing Home Residents". This study will examine therapeutic and adverse effects of continuing versus discontinuing antidepressant medication in nursing home residents who have had no more than a single episode of depression and who no longer have depressive symptoms.
What is the current status of trial NCT00076622?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2003-11. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00076622?
The interventions under investigation include: Antidepressant medication (DRUG), No antidepressant medication (DRUG).
Who is sponsoring clinical trial NCT00076622?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia